New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
08:02 EDTXRAY, DHRDanaher, DENTSPLY seen as interested in Nobel Biocare, Bloomberg says
Swiss dental implant maker Nobel Biocare, which was initially approached by buyout firm EQT Partners and then hired Goldman Sachs (GS) as an advisor, has attracted interest from Danaher (DHR), said Bloomberg, citing people with knowledge of the matter. Other buyout firms and companies such as DENTSPLY (XRAY) and are also expected to look at Nobel, the report added. Reference Link
News For DHR;XRAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
09:16 EDTDHRDanaher price target raised to $93 from $85 at RW Baird
Subscribe for More Information
07:19 EDTDHRDanaher priced target raised to $94 from $88 at BofA/Merrill
Subscribe for More Information
December 11, 2014
06:04 EDTDHRDanaher sees FY15 adjusted EPS $4.35-$4.45, consensus $4.01
Subscribe for More Information
06:02 EDTDHRDanaher backs Q4 EPS view of $1.00-$1.04, consensus $1.02
December 9, 2014
13:45 EDTDHRDanaher to host investor and analyst meeting
Subscribe for More Information
December 8, 2014
07:53 EDTDHRDanaher price target raised to $100 from $89 at Jefferies
Jefferies raised its price target for Danaher shares to $100 ahead of the company's investor day and keeps a Buy rating on the name. It expects an initial 2015 organic growth outlook of 3% and earnings guidance of $3.95 and ex-amortization $4.40. Jefferies keeps a Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use